Skip to main content
. 2017 Aug 21;20(3):400–410. doi: 10.1093/neuonc/nox155

Table 3.

Treatment compliance and duration

Resection N Total Days,
mean ± SD
Interval from diagnosis to resection 10 ± 15.2
Resection compliance 30 (100%)
Grade of resection
Complete 15 (50.0%)
Partial 8 (26.7%)
Biopsy 0 (0.0%)
Data not available 7 (23.3%)
Average percent of resection (in MRI) 94.7% ± 12.4%
Radiochemotherapy Number of patients; median days (% of total)
Interval from resection to radiochemotherapy 53.0 ± 24
Interval from radiochemotherapy to adjuvant chemotherapy 48.0 ± 79
Radiotherapy per protocol 30 (100%)
Concomitant chemotherapy
 Less than 4 doses of vincristine (VCR) 2 (6.6%)
 4–6 doses of VCR 16 (53.3%)
 7–8 doses of VCR 12 (40.0%)
Maintenance chemotherapy Number of patients (% of total)
Interval from resection to adjuvant chemotherapy 166 ± 76.5
Dropout rate
 By cycle 1 5 (16.7%)
 By cycle 2 5 (16.7%)
 By cycle 3 9 (30.0%)
 By cycle 4 9 (30.0%)
 By cycle 5 9 (30.0%)
 By cycle 6 11 (36.7%)
 By cycle 7 17 (56.7%)
 By cycle 8 20 (66.7%)
Cycles of chemotherapy given 155 (100%)
Cycles given per protocol 77 (49.7%)

Note. Time to start of each treatment part was calculated from time of tumor resection to first day of the respective treatment. Extent of resection was calculated from postoperative MRI, and compliance to radiochemotherapy and maintenance chemotherapy was extracted. Data were calculated in the intent-to-treat population.